Table 3 Final pathology results of patients with “suspicious” Afirma® GEC results
From: The first Canadian experience with the Afirma® gene expression classifier test
Underwent surgery | Benign | Malignant | |
|---|---|---|---|
Montreal | 44 | 23 (52%) | 21 (48%) |
St. John’s | 33 | 16 (48%) | 17 (52%) |
Total | 77 | 39 (51%) | 38 (49%) |